Skip to content
drillr.ai
Sign up

RNA

Avidity Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$14.19
−2.81%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+19.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jan 23, 2026Hughes Steven George · officer: Chief Medical OfficerSale2,017$72
Jan 23, 2026Hughes Steven George · officer: Chief Medical OfficerSale2,878$72
Jan 23, 2026Boyce Sarah · director, officer: President and CEOSale6,394$72
Jan 23, 2026Boyce Sarah · director, officer: President and CEOSale7,993$72
Jan 23, 2026Flanagan W. Michael · officer: Chief Scientific OfficerSale3,976$72
Jan 23, 2026Flanagan W. Michael · officer: Chief Scientific OfficerSale2,558$72
Jan 23, 2026MacLean Michael F · officer: Chief Financial OfficerSale1,807$72
Jan 23, 2026MacLean Michael F · officer: Chief Financial OfficerSale2,735$72
Jan 23, 2026LEVIN ARTHUR A · directorSale1,758$72
Jan 23, 2026McCarthy Teresa · officer: Chief Human Resources OfficerSale1,476$72
Jan 23, 2026McCarthy Teresa · officer: Chief Human Resources OfficerSale1,453$72
Jan 9, 2026Boyce Sarah · director, officer: President and CEOSale8,576$72
Jan 9, 2026Calderaro Charles III · officer: Chief Technical OfficerSale3,727$72
Jan 9, 2026McCarthy Teresa · officer: Chief Human Resources OfficerSale1,965$72
Jan 9, 2026Moriarty John B · officer: Chief Legal OfficerSale2,374$72
Jan 9, 2026MacLean Michael F · officer: Chief Financial OfficerSale1,974$72
Jan 9, 2026Hughes Steven George · officer: Chief Medical OfficerSale2,373$72
Jan 9, 2026Flanagan W. Michael · officer: Chief Scientific OfficerSale2,373$72
Dec 19, 2025Calderaro Charles III · officer: Chief Technical OfficerA-Award23,250$0.00
Dec 19, 2025Calderaro Charles III · officer: Chief Technical OfficerF-InKind9,726$72
Dec 19, 2025Flanagan W. Michael · officer: Chief Scientific OfficerA-Award27,500$0.00
Dec 19, 2025Flanagan W. Michael · officer: Chief Scientific OfficerF-InKind13,695$72
Dec 19, 2025Mosbrooker Eric · officer: Chief Commercial OfficerA-Award72,000$0.00
Dec 19, 2025Mosbrooker Eric · officer: Chief Commercial OfficerF-InKind36,564$72
Dec 19, 2025Mosbrooker Eric · officer: Chief Commercial OfficerF-InKind11,426$72
Dec 19, 2025Boyce Sarah · director, officer: President and CEOA-Award31,000$0.00
Dec 19, 2025Boyce Sarah · director, officer: President and CEOF-InKind15,742$72
Dec 19, 2025Moriarty John B · officer: Chief Legal OfficerA-Award56,000$0.00
Dec 19, 2025Moriarty John B · officer: Chief Legal OfficerF-InKind26,824$72
Dec 19, 2025Gallagher Kathleen P. · officer: Chief Program OfficerA-Award72,000$0.00
Institutional positioning

13F filings over the trailing two quarters

New 64Increased 63Reduced 167Sold out 54
FilerActionSharesFiled
AVORO CAPITAL ADVISORS LLCReduced5,455,000Mar 16, 2026
GOLDMAN SACHS GROUP INCIncreased3,776,785Mar 25, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased1,553,210May 15, 2026
Sessa Capital IM, L.P.Increased1,500,000Aug 14, 2026
PRICE T ROWE ASSOCIATES INC /MD/Reduced1,472,984Aug 14, 2026
BlackRock, Inc.Increased1,447,476Aug 7, 2026
BLACKROCK, INC.Reduced1,205,291May 13, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced1,030,143May 15, 2026
RA CAPITAL MANAGEMENT, L.P.Reduced864,102May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced840,600Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased730,831Aug 13, 2026
CRCM LPNew Position641,539Aug 18, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position626,869May 15, 2026
TIG ADVISORS, LLCReduced607,552May 15, 2026
PENTWATER CAPITAL MANAGEMENT LPReduced602,649May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 23, 2026